nsclc - Robuta Search

https://www.harmonictrial.com/ Harmonic™ Clinical Trial for Never Smokers With NSCLC Harmonic™ Clinical Trial: A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma clinical trial never smokers nsclc https://www.mesotheliomadr.com/news/zykadia-a-new-drug-for-the-treatment-of-metastatic-non-small-cell-lung-cancer Zykadia Treats Metastatic NSCLC | MesotheliomaDR Ceritinib, sold under the name of Zykadia by Novartis, was found efficient in treating metastatic non-small cell lung cancer. treats metastatic nsclc https://deceraclinical.com/education/program/oncology/treatment-in-egfr-mutated-nsclc/50516 Personalized Treatment in EGFR-Mutated NSCLC: Applying the Latest Clinical Evidence to Address... Gain expert insights into the latest clinical data on EGFR-mutated NSCLC to guide treatment selection and improve patient outcomes and quality of life through... https://ecancer.org/en/video/7776-the-role-of-afatinib-in-patients-with-egfr-nsclc The role of afatinib in patients with EGFR NSCLC - ecancer Dr Antonio Passaro speaks to ecancer at the European Lung Cancer Congress 2019. He outlines the Phase III trial which evaluates the role of afatinib in the role of in patients afatinib egfr nsclc https://ecancer.org/en/video/8278-comment-immunotherapy-combination-for-advanced-nsclc Comment: Immunotherapy combination for advanced NSCLC - ecancer Dr Marina Garassino speaks to ecancer at ESMO 2019 in Barcelona commenting on the CheckMate-227 trial, which uses nivolumab plus low-dose ipilimumab to treat for advanced comment immunotherapy combination nsclc https://www.spandidos-publications.com/10.3892/or.2016.4784 Safflower polysaccharide induces NSCLC cell apoptosis by inhibition of the Akt pathway Oncology Reports is an international journal devoted to fundamental and applied research in Oncology. https://medically.roche.com/nz/en/oncology/diseases/lung-cancer/materials/esmo-2021-video-lopes-03.html Plinabulin plus docetaxel promising in second-, third-line NSCLC treatment plus docetaxel promising second third https://ecancer.org/en/news/17036-fda-approves-atezolizumab-with-nab-paclitaxel-and-carboplatin-for-metastatic-nsclc-without-egfr-alk-aberrations FDA approves atezolizumab with nab-paclitaxel and carboplatin for metastatic NSCLC without EGFR/ALK... The Food and Drug Administration (FDA) approved atezolizumab in combination with paclitaxel protein-bound and carboplatin for the first-line treatment of adu https://christie.openrepository.com/items/e9551c35-0330-4a77-ae80-358837a9fc75 Editorial: biomarker-guided strategies in NSCLC immunotherapy editorial biomarker guided strategies nsclc https://healthandpharma.net/opdivo-nivolumab-chemotherapy-lung-cancer-nsclc Nivolumab Plus Chemotherapy Demonstrates Survival Benefit in Resectable NSCLC May 9, 2026 - The CheckMate -816 trial shows nivolumab plus platinum-doublet chemotherapy significantly improves overall survival in resectable non-small cell lung cancer. nivolumab plus chemotherapy demonstrates survival https://www.trillium.de/akademie/cme-portal/fortschritte-in-der-therapie-des-mutierten-nsclc-aktuelle-standards-und-zukuenftige-perspektiven-uebersicht.html Fortschritte in der Therapie des mutierten NSCLC - Aktuelle Standards und zukünftige Perspektiven |... https://unifind.unisr.it/resource/item/81749?language=en-US UniSR - UNIFIND - Efficacy of sorafenib in BRAF-mutated nonsmall- cell lung cancer (NSCLC) and no... Unifind is a portal where you can discover the expertise within a university by searching among experts, courses, professions, people, publications, and... https://ctv.veeva.com/study/dynamic-changes-of-circulating-tumor-dna-in-late-stage-nsclc-patients Dynamic Changes of Circulating Tumor DNA in Late Stage NSCLC Patients A multi-centre observational, non-interventional study is to dynamically monitor the changes of circulating tumor DNA (ctDNA) in late stage NSCLC patients... late stage dynamic changes circulating tumor https://www.med-chemist.com/search/label/ALK-positive%20non-small%20cell%20lung%20cancer%20%28NSCLC%29 Med-Chemist: ALK-positive non-small cell lung cancer (NSCLC) small cell lung cancer med chemist alk positive https://visualping.io/pages/nivolumab-vs-chemo-in-stage-iv-nsclc-clinical-trial-alerts-4962386 Nivolumab vs Chemo in Stage IV NSCLC Clinical Trial: Get alerts for the latest updates - Visualping See the latest updates to Nivolumab vs Chemo in Stage IV NSCLC Clinical Trial. Subscribe for free to get alerts when changes are detected to Nivolumab vs Chemo... https://winactiekaart.com/article/neoadjuvant-chemoimmunotherapy-for-nsclc-surgical-outcomes-and-challenges Neoadjuvant Chemoimmunotherapy for NSCLC: Surgical Outcomes and Challenges (2026) May 13, 2026 - The world of thoracic surgery is undergoing a profound transformation, and a recent meta-analysis by Bertoglio and colleagues is shedding light on the impact... surgical outcomes nsclc challenges https://turkjpath.org/abstract.php?id=2122 NGS-Based Mutation Profiling and PD-L1 Expression in NSCLC Patients: A Single-Centre Prospective... NGS-Based Mutation Profiling and PD-L1 Expression in NSCLC Patients: A Single-Centre Prospective Analysis https://www.cancernetwork.com/view/setting-expectations-for-long-term-therapy-in-egfr-mutated-nsclc Setting Expectations for Long-Term Therapy in EGFR-Mutated NSCLC | CancerNetwork May 15, 2026 - In this segment, Dr. Alexander Spira and Dr. Natalie Vokes discuss how to effectively counsel patients starting adjuvant EGFR tyrosine kinase inhibitor therapy... setting expectations long term https://nsclc-advances.com/ NSCLC – ADVANCES Initiative nsclc advances initiative https://mesotheliomacancerlawyer.net/blog/squamous-nsclc-treatment-2/ Squamous Nsclc Treatment Jan 12, 2025 - Squamous non-small cell lung cancer (NSCLC) is a subtype of lung cancer that arises from the squamous cells lining the airways. This type of cancer.. squamous nsclc treatment https://pure.fujita-hu.ac.jp/en/publications/volume-based-parameters-measured-by-using-fdg-petct-in-patients-w/ Volume-based parameters measured by using FDG PET/CT in patients with stage i NSCLC treated with... https://scholarx.skku.edu/item/59adc5b3-20f0-4a93-8803-c72e563225fa ScholarWorks :: Exploiting Dependencies Created By KEAP1/NFE2L2 Mutations in NSCLC to Overcome... created by https://lavitaconilcancroalpolmone.it/microcitoma/microcitoma-ho-ricevuto-la-diagnosi/forme-frequenza/ NSCLC: Forme e Frequenza del Tumore al Polmone Non a Piccole Cellule May 28, 2025 - Approfondimento sul NSCLC (tumore al polmone non a piccole cellule): tipologie, incidenza e statistiche. tumore al polmone https://www.clinicaltrialsarena.com/news/iteos-gsk-nsclc-trial/ iTeos and GSK begin Phase III trial of NSCLC treatment regimen Jun 18, 2024 - iTeos Therapeutics and GSK have begun a Phase III trial of belrestotug plus dostarlimab for treating non-small cell lung cancer (NSCLC). phase iii gsk begin https://fair.unifg.it/handle/11369/416898 Exhaled Breath Temperature Home Monitoring to Detect NSCLC Relapse: Results from a Pilot Study https://stage.cancerimagingarchive.net/tcia-downloads/nsclc-radiomics-genomics-da-rad/tcia_nsclc-radiomics-genomics_06-22-2015-nbia-digest/ TCIA_NSCLC-Radiomics-Genomics_06-22-2015-nbia-digest - The Cancer Imaging Archive (TCIA) Feb 16, 2025 - TCIA_NSCLC-Radiomics-Genomics_06-22-2015-nbia-digest https://scholars.mssm.edu/en/publications/tissue-resident-macrophages-provide-a-pro-tumorigenic-niche-to-ea-2/ Tissue-resident macrophages provide a pro-tumorigenic niche to early NSCLC cells - Icahn School of... https://aceatherapeutics.com/patients/lung-cancer-nsclc/ EGFR-mutant Non-Small Cell Lung Cancer (NSCLC) - ACEA Aug 23, 2023 - Lung cancer is the most prevalent form of cancer in the world and is notoriously difficult to treat. Approximately 230,000 people are diagnosed with lung...... small cell lung cancer egfr mutant non nsclc https://longoncologie.nl/amivantamab-plus-lazertinib-effectiever-dan-osimertinib-bij-nsclc-met-egfr-mutaties/ Amivantamab plus lazertinib effectiever dan osimertinib bij NSCLC met EGFR-mutaties -... Oct 12, 2023 - Volgens de fabrikant van zowel amivantamab als lazertinib presteerde de combinatie van deze middelen in de MARIPOSA fase 3-studie beter dan osimertinib.[1] Het... plus dan https://ecancer.org/en/video/5267-pembrolizumab-should-be-first-line-treatment-for-high-pd1-expressing-nsclc-patients Pembrolizumab 'should be first line treatment' for high PD1 expressing NSCLC patients - ecancer Dr Reck presents, at a press conference at ESMO 2016, results from the KEYNOTE-024 trial which he believes recommend the use of PD1 antibody pembrolizumab as https://www.pihealthcancerhospital.com/blog/nivolumab-a-comparison-of-efficacy-in-treating-metastatic-nsclc/ Nivolumab: A Comparison of Efficacy in Treating Metastatic NSCLC - Pi Health Cancer Hospital Dec 26, 2024 - Nivolumab is an immune checkpoint inhibitor that works by blocking the PD-1 protein, which is found on the surface of T-cells, a type of white blood cell that... https://ora.uniurb.it/handle/11576/2709750 Tumor burden as possible biomarker of outcome in advanced NSCLC patients treated with... https://www.oaepublish.com/articles/2394-4722.2025.136 Circulating tumor DNA (ctDNA) in early-stage NSCLC: a new frontier in precision oncology Recent advances in the management of early-stage non-small cell lung cancer (NSCLC), including perioperative immunotherapy and targeted treatments, have... https://lungcancersymptomsx.com/drug-tagrisso-osimertinib-to-treat-nsclc.html Drug: Tagrisso (Osimertinib) to Treat NSCLC - Lung Cancer Blog Sep 17, 2018 - Osimertinib or Tagrisso is an FDA-approved drug by FDA as a frontline treatment for patients with non-small cell lung cancer (NSCLC). It is indicated for the... lung cancer drug osimertinib treat nsclc https://marquismedical.net/fdg-pet-shows-tumor-dna-levels-in-blood-are-linked-to-nsclc-aggressiveness/ Marquis MedicalFDG PET Shows Tumor DNA Levels in Blood Are Linked to NSCLC Aggressiveness - Marquis... Nov 6, 2017 - The perfect solution for all your PET/CT service needs https://www.lungevity.org/learn-about-lungevity/precision-medicine/clinical-value-of-biomarker-testing-in-nsclc Clinical Value of Biomarker Testing in NSCLC | LUNGevity Foundation Biomarker testing is essential for clinical care in NSCLC and must be part of standardized workflows. clinical value biomarker testing nsclc foundation https://fad.accmed.org/course/info.php?id=1956 NSCLC KRAS Mutato e SCLC: percorsi terapeutici a confronto nsclc kras mutato e confronto https://scholar.usuhs.edu/en/publications/molecular-targeted-drugs-and-biomarkers-in-nsclc-the-evolving-rol/ Molecular targeted drugs and biomarkers in NSCLC the evolving role of individualized therapy -... https://ascopost.com/issues/april-25-2026/ai-driven-multiagent-system-for-guiding-first-line-immunotherapy-for-nsclc/ AI-Driven Multiagent System for Guiding First-Line Immunotherapy for NSCLC - The ASCO Post An artificial intelligence (AI) multiagent system demonstrated correct and complete reasoning in determining the use of immunotherapy for patients with... https://www.opdivo.com/nsclc/clinical-trial-results/stage-2a-to-3b-immunotherapy-chemo-surgery Stage 2A to 3A Early-Stage Non-Small Cell Lung Cancer (NSCLC) | Clinical Trial Results | OPDIVO®... See how OPDIVO® (nivolumab) plus chemotherapy infusions followed by surgery and additional OPDIVO® monotherapy performed in clinical trials for treating stage... https://connect.uclahealth.org/dom/tag/nsclc/page/3/ NSCLC | Department of Medicine Blog department of medicine nsclc blog https://dzl.de/publication/10-21037-jtd-2018-05-61/ EML4-ALK V3, treatment resistance, and survival: refining the diagnosis of ALK(+) NSCLC - Deutsches... Christopoulos, P. Kirchner, M. Endris, V. Stenzinger, A. Thomas, M. https://pubmed.ncbi.nlm.nih.gov/26076459/ Combined Targeted DNA Sequencing in Non-Small Cell Lung Cancer (NSCLC) Using UNCseq and NGScopy,... The recent FDA approval of the MiSeqDx platform provides a unique opportunity to develop targeted next generation sequencing (NGS) panels for human disease,... https://www.spooky2.nl/testimonial/nsclc-stadium-4-overwinnen/ NSCLC Stadium 4 overwinnen - Spooky2 Nederland Sep 9, 2024 - Mij is vaak gevraagd wat mij zo gepassioneerd maakt over wat ik doe; mijn leven. De waarheid is dat gedurende nsclc stadium nederland https://radioxlogs.com/2025/08/20/nodal-clues-shift-nsclc-treatment-path/ Nodal Clues Shift NSCLC Treatment Path - RadioXlogs - The Radiology News Aggregator Aug 20, 2025 - Dr Coral Olazagasti walks through staging and treatment strategy in a newly diagnosed NSCLC case. MedscapeRead the full article on medscape.com radiology news nodal clues shift nsclc https://ecancer.org/en/video/7992-pembrolizumab-increases-long-term-survival-in-patients-with-advanced-nsclc Pembrolizumab increases long-term survival in patients with advanced NSCLC - ecancer Dr Jorge Nieva speaks to ecancer at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting about the latest results from the KEYNOTE-001 study, long term in patients advanced nsclc pembrolizumab increases https://www.bmsstudyconnect.com/ca/fr/clinical-trials/NCT01024062.html Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Non-Small Cell Lung Cancer (NSCLC)... The purpose of this study is to evaluate the efficacy and the safety of paclitaxel given weekly in patients with advanced or recurrent non-small cell lung... https://research.uniupo.it/it/publications/antibiotic-exposure-and-immune-checkpoint-inhibitors-in-patients-/ Antibiotic Exposure and Immune Checkpoint Inhibitors in Patients With NSCLC: The Backbone Matters -... immune checkpoint inhibitors https://powerfulpatients.org/resource/activated-nsclc-biomarkers-patient-plan/ [ACT]IVATED NSCLC Biomarkers Patient Plan - Patient Empowerment Network Apr 7, 2026 - Receive via email a custom non-small cell lung cancer patient plan featuring a collection of vetted resources. act nsclc biomarkers patient plan https://www.themednet.org/can-ctdna-be-used-to-evaluate-response-to-checkpoint-inhibitors-in-nsclc-when-pseudoprogression-is-suspected-on-ct-imaging Can ctDNA be used to evaluate response to checkpoint inhibitors in NSCLC when pseudoprogression is... Physician discussion: Can ctDNA be used to evaluate response to checkpoint inhibitors in NSCLC when pseudoprogression is suspected on CT imaging?. See expert... https://go2.org/blog/fda-approves-brigatinib-for-alk-positive-metastatic-nsclc FDA Approves brigatinib for ALK-positive Metastatic NSCLC fda alk positive metastatic nsclc https://mymedisage.com/news/clinical-outcomes-and-resistance-mechanisms-in-ros1-fusion-positive-nonsmall-cell-lung-cancer ROS1+ NSCLC: Real-World Outcomes and Resistance to Crizotinib and Lorlatinib Real-world study of ROS1+ NSCLC reveals limited TKI efficacy and resistance to lorlatinib in G2032R and L2026M mutations, underscoring the impact of molecular r real world nsclc outcomes resistance crizotinib https://scholarx.skku.edu/item/20e7c864-82df-4bc7-8009-2adcd329c3f9 ScholarWorks :: EcDNA-mediated oncogene amplification underlies EGFR TKI resistance in NSCLC. scholarworks mediated oncogene amplification https://app.quri.ai/trials/NCT07560111/a-phase-ii-study-of-gc101-in-nsclc A Phase II Study of GC101 in NSCLC (NCTNCT07560111) - Patient Guide & Enrollment Help Connect with this clinical trial through Quri.ai's free matching service. A Phase II Study of GC101 in NSCLC (NCTNCT07560111). Get matched to the right... https://www.texasoncology.com/clinical-trials/24149-Ph-3-Study-of-Nivo-Relatlimab-w-Chemo-vs-Pembro-w-Chemo-FL-NSQ-NSCLC-PD-L1 Ph 3 Study of Nivo + Relatlimab w/ Chemo vs Pembro w/Chemo FL NSQ NSCLC PD-L1 | Clinical Trial |... Learn more about Phase III Clinical Trial for Lung Cancer at Texas Oncology. https://www.erasmusmc.nl/nl-nl/kankerinstituut/patientenzorg/aandoeningen/niet-kleincellige-longkanker Niet-kleincellige longkanker (NSCLC) NSCLC ofwel Niet-kleincellig longcarcinoom: soorten, oorzaak, symptomen en behandelingen niet longkanker nsclc https://www.med-chemist.com/2018/03/fda-approves-new-indication-for.html Med-Chemist: FDA Approves New Indication for Gilotrif (afatinib) in EGFR Mutation-Positive NSCLC https://scholar.xjtu.edu.cn/zh/publications/reversing-met-mediated-resistance-in-oncogene-driven-nsclc-by-met/ Reversing MET-Mediated Resistance in Oncogene-Driven NSCLC by MET-Activated Wnt Condensative... https://agilusdiagnostics.com/package/chennai/100027226/nsclc-therapy-panel Nsclc Therapy Panel Package in Chennai | Agilus Diagnostics Affordable Nsclc Therapy Panel Package in Chennai. Quick, accurate, and reliable testing services. Book your appointment today! nsclc therapy panel package chennai https://medically.roche.com/nz/en/oncology/diseases/non-small-cell-lung-cancer/2022-04-27-jessica-donington-she-v1-1080p.html The role of surgery in early-stage NSCLC management the role of early stage surgery nsclc management https://www.macmillan.org.uk/cancer-information-and-support/treatments-and-drugs/gefitinib Gefitinib - targeted therapy drug to treat NSCLC | Macmillan Cancer Support Gefitinib is a targeted therapy drug. It is used to treat non-small cell lung cancer (NSCLC) that has spread. Learn more about it. targeted therapy gefitinib drug treat nsclc https://pubmed.ncbi.nlm.nih.gov/30738830/?dopt=Abstract FoxO3a inhibiting expression of EPS8 to prevent progression of NSCLC: A new negative loop of EGFR... National Natural Science Foundation of China, Science and Technology Project of Henan, Outstanding Young Talent Research Fund of Zhengzhou University and the... https://bpno.no/medtalks/wclc2020-pre-operative-treatment-with-atezolizumab-in-untreated-stage-ib-iiib-resectable-nsclc/ WCLC2020: Pre-operative treatment with atezolizumab in untreated stage IB-IIIB resectable NSCLC Jul 26, 2024 - Jay M. Lee present data for pre-operative treatment with atezolizumab of patients without EGFR/ALK mutations who underwent surgery. https://r9.risteys.finngen.fi/endpoints/C3_NSCLC_SQUAM_EXALLC Risteys FinnGen R9 - C3_NSCLC_SQUAM_EXALLC nsclc squam https://www.cic.vc/inivata-highlights-new-clinical-data-on-invisiontm-ctdna-liquid-biopsy-platform-in-advanced-nsclc-at-wclc-2017/ Inivata highlights new clinical data on InVision(TM) ctDNA liquid biopsy platform in advanced NSCLC... Aug 1, 2025 - Inivata, a global clinical cancer genomics company utilizing an industry-leading liquid biopsy platform to transform patient care, today announces that new... https://www.medinfo.rs/therapeutic-areas/oncology/lung-cancer/oncogenic-mutations-in-nsclc.html Onkogene mutacije kod NSCLC-a kod nsclc https://cms.biodesix.com/tag/horizon-bcbs-new-jerseynsclc-testpress-releasesveristrat-coveredliquid-biopsylung-cancer-biomarkersproteomic-biomarkers/ Horizon BCBS New Jersey,NSCLC test,Press Releases,Veristrat covered,liquid biopsy,lung cancer... https://www.opdivo.com/nsclc Non-Small Cell Lung Cancer (NSCLC) Treatment | OPDIVO® & OPDIVO Qvantig® OPDIVO® or OPDIVO Qvantig® alone, or with YERVOY® can be used as an immunotherapy treatment option for adults with certain types of NSCLC. Please see... small cell lung cancer non nsclc treatment opdivo https://resources.advancedpractitioner.com/biomarkers-in-nsclc/news/trastuzumab-deruxtecan-in-her2-mutant-non-small-cell-lung-cancer/ Biomarkers in NSCLC biomarkers nsclc https://dailyreporter.esmo.org/esmo-congress-2023/non-small-cell-lung-cancer/amivantamab-combination-therapies-emerge-as-new-options-for-egfr-mutated-advanced-nsclc New treatment options for EGFR-mutated advanced NSCLC Clinically meaningful improvements with amivantamab combination therapies over standard care were observed in both first and second line new treatment options egfr advanced nsclc https://www.canceropole-est.org/la-recherche-au-sein-du-canceropole-est/annuaires/publications-scientifiques/detail/?id=33425 Surveillance After Curative-Intent Treatment for NSCLC: More to It Than Meets the Eye. -... https://www.iomedico.com/publikation/overall-survival-and-sequential-treatment-of-patients-with-advanced-nsclc-in-german-outpatients-centres-data-from-the-clinical-tlk-registry/ Overall survival and sequential treatment of patients with advanced NSCLC in German outpatients... Gemeinsam forschen gegen Krebs https://globaloncologyacademy.org/programs/project-oncology/managing-brain-metastases-in-alk-nsclc/54575/ Managing Brain Metastases in ALK+ NSCLC - Managing Brain Metastases in ALK+ NSCLC brain metastases managing alk nsclc https://anngonkhoe.com/tag/nsclc/ NSCLC Archives - Eat Better & Live Healthier eat better nsclc archives live healthier https://www.clinicaltrialsarena.com/news/merck-moderna-cancer-vaccine-keytruda-trial-nsclc/ Merck and Moderna start cancer vaccine and Keytruda combo trial in NSCLC Dec 12, 2023 - Merck and Moderna are also conducting a Phase III trial evaluating the combination therapy in patients with resected high-risk melanoma. cancer vaccine merck moderna start https://www.grupogallegocancerdepulmon.org/comunicaciones-congresos/concurrent-chemoradiation-cchrt-for-locally-advanced-stage-iii-non-small-cell-lung-cancer-nsclc-with-cisplatin-and-vinorelbine-and-thoracic-radiotherapy-a-phase-ii-study-from-the-galician-lung-ca/ Concurrent Chemoradiation (CChRT) for locally advanced stage III Non-Small Cell Lung Cancer (NSCLC)... Jun 15, 2022 - 2017 ASCO Annual Meeting small cell lung cancer https://www.biospace.com/dizal-s-sunvozertinib-approved-by-china-nmpa-with-potential-for-best-in-class-therapy-in-nsclc-with-egfr-exon20ins-mutations Dizal's Sunvozertinib Approved by China NMPA with Potential for Best-in-class Therapy in NSCLC with... Aug 23, 2023 - Dizal today announced that sunvozertinib has been approved by the National Medical Products Administration (NMPA) of China for the treatment of adult patients... https://www.iqwig.de/en/presse/press-releases/press-releases-detailpage_49472.html Adjuvant treatment of NSCLC: Certain patients benefit from osimertinib. Hint of considerable added benefit if adjuvant platinum-based chemotherapy has already been administered after complete tumour resection or is not suitable. adjuvant treatment nsclc certain patients https://findtrial.co/trial/ChiCTR2000037269 PD-1 inhibitor plus chemotherapy and VEGFR inhibitor or placebo in advanced non-squamous NSCLC... Clinical trial for lung cancer https://dailyreporter.esmo.org/esmo-congress-2021/no-title/positive-early-clinical-results-for-amivantamab-plus-lazertinib-in-nsclc Positive early results for amivantamab plus lazertinib in NSCLC Two phase I trials in patients with advanced EGFR-mutated NSCLC demonstrate promising potential of targeted therapy with amivantamab plus lazertinib positive early results plus nsclc https://repositori.upf.edu/items/3337b78d-96f9-423a-9ef6-8f6adeb13d09 e-Repositori UPF :: RET fusion testing in patients with NSCLC: The RETING study Introduction: RET inhibitors with impressive overall response rates are now available for patients with NSCLC, yet the identification of RET fusions remains a... https://ahecblog.com/tag/nsclc/ NSCLC - AHECBLOG nsclc https://www.thepharmaletter.com/biotech-news/medimmune-and-mirati-team-up-on-durvalumab-mocetinostat-for-non-small-cell-lung-cancer MedImmune and Mirati team up on durvalumab/mocetinostat for NSCLC | Biotechnology | The... MedImmune, the global biologics research and development arm of Anglo-Swedish drug major AstraZeneca has entered into an exclusive clinical trial collaboration team up https://education.nccn.org/TARGET TARGET FOR NSCLC: The Advancing Research into Genomic Pathways and use of EGFR Therapies | NCCN... https://egfrcancer.org/2020/11/11/2020-annual-egfr-resisters-research-summit-wrap-up-2/ 1st Drug for MET+ NSCLC Shows High Response Rates | EGFR Lung Cancer Resisters Jan 11, 2024 - The first targeted therapy for patients with advanced NSCLC harboring MET mutations, capmatinib (Tabrecta), has shown deep and durable responses. https://www.natera.com/resource-library/oncology/signatera-mrd-testing-for-nsclc-patient-managemet/ Signatera MRD Testing for NSCLC Patient Management mrd testing nsclc patient management https://simhcottumwa.org/atezolizumab-monotherapy-beneficial-for-nsclc-ineligible-for-platinum-based-chemo/ Atezolizumab Monotherapy Beneficial for NSCLC Ineligible for Platinum-Based Chemo - Southern Iowa... Aug 15, 2023 - TUESDAY, Aug. 15, 2023 (HealthDay News) -- For patients with non-small cell lung cancer (NSCLC) ineligible for platinum-based chemotherapy, first-line... beneficial nsclc